PMID: 9420207Jan 7, 1998Paper

Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop a severe AIDS-like disease

Journal of Virology
Zaher HannaPaul Jolicoeur

Abstract

We have constructed transgenic (Tg) mice expressing the entire human immunodeficiency virus type 1 (HIV-1) coding sequences in cells targeted by HIV-1 infection in humans. These Tg mice developed a severe AIDS-like disease leading to early death (< 1 month). They developed muscle wasting, severe atrophy and fibrosis of lymphoid organs, tubulointerstitial nephritis, and lymphoid interstitial pneumonitis. In addition the expression of RANTES was increased in various tissues of these Tg mice relative to that in the normal controls. Disease appearance was correlated with the levels of transgene expression. The numerous pathologies observed in these mice are remarkably similar to those observed in human AIDS and, more specifically, in pediatric AIDS.

References

Jun 1, 1992·Journal of Virology·P JolicoeurN Beaulieu
Oct 1, 1992·AIDS·Y IwakuraH Shibuta
Mar 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·J B KoppP E Klotman
Jul 30, 1992·The New England Journal of Medicine·C Grunfeld, K R Feingold
Mar 1, 1990·AIDS Research and Human Retroviruses·A De RossiL Chieco-Bianchi
Jul 1, 1990·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·F D SeneyF G Silva
Dec 28, 1989·The New England Journal of Medicine·G B ScottW P Parks
Sep 7, 1989·The New England Journal of Medicine·J StraussV Pardo
Nov 19, 1987·The New England Journal of Medicine·R RothenbergB Truman
Dec 1, 1974·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·I W McLean, P K Nakane
Aug 1, 1995·Kidney International·M H Humphreys
Mar 1, 1995·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·U SüttmannM J Müller
Jul 1, 1994·Pediatric Hematology and Oncology·V V Joshi
Nov 1, 1994·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·I BódiP L Kimmel
Sep 1, 1994·Journal of Leukocyte Biology·S M Crowe, R S Kornbluth
Dec 20, 1995·Archives of Biochemistry and Biophysics·F A BettelheimP Russell
Jan 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·H SchmidtmayerovaB Sherry
May 24, 1996·Science·D D Ho
Feb 10, 1996·AIDS Research and Human Retroviruses·P Dickie
Aug 10, 1996·AIDS Research and Human Retroviruses·P DickieL J Chang
Nov 7, 1996·The New England Journal of Medicine·A P KourtisS Nesheim
Mar 15, 1997·AIDS·G N GaultonM Rosenzweig

❮ Previous
Next ❯

Citations

Oct 6, 2005·American Journal of Physiology. Renal Physiology·Scott Martinka, Leslie A Bruggeman
Aug 5, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Elena PriceputuPaul Jolicoeur
Jan 20, 2011·Infection and Immunity·Collin R Diedrich, Joanne L Flynn
Oct 16, 2002·Proceedings of the National Academy of Sciences of the United States of America·Cheryl TwuMilan Fiala
Oct 19, 2004·Clinical Microbiology Reviews·Louis de RepentignyPaul Jolicoeur
Jul 1, 2008·Expert Review of Anti-infective Therapy·Mohamed G AttaDerek M Fine
Apr 13, 2006·Current Opinion in Nephrology and Hypertension·Ting-Chi LuPaul Klotman
Mar 15, 2012·Viral Immunology·Giorgio ManginoElisabetta Affabris
Nov 30, 2011·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Ricky MaungMarcus Kaul
Aug 30, 2013·Retrovirology·Sabrina CurreliJoseph Bryant
Mar 31, 2012·Clinical & Developmental Immunology·Johanne PoudrierMichel Roger
May 21, 2016·PloS One·Julie GauvinUNKNOWN Montreal Primary HIV Infection and Slow Progressor Cohorts
Feb 8, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Eleonora OlivettaMaurizio Federico
Aug 18, 2006·Journal of the American Society of Nephrology : JASN·Mamdouh AlbaqumiPeter J Nelson
Sep 19, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Leslie A Bruggeman
Sep 29, 2004·Journal of Virology·Ming-Bo HuangVincent C Bond
May 27, 2006·American Journal of Respiratory and Critical Care Medicine·John C MareckiSonia C Flores
Feb 22, 2011·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·John L FosterJ Victor Garcia
Feb 6, 2010·Journal of Cardiovascular Electrophysiology·Scott A GrandyCéline Fiset
Sep 19, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Krzysztof KirylukAli G Gharavi
Sep 16, 2020·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Rowan SalonerUNKNOWN Translational Methamphetamine AIDS Research Center (TMARC) Group
May 15, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Véronique DufourJacques Cadranel
Sep 25, 2009·Nature Reviews. Nephrology·Leslie A Bruggeman, Peter J Nelson
Apr 20, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Paul G F KoenenKiki Tesselaar
Sep 19, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Christina M Wyatt, Paul E Klotman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.